References
Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP. The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer 1984;33:441–445
Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A, et al. Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 1999;17:3058–3063
Going JJ, Stanton PD, Cooke TG. Influences on measurement of cellular proliferation by histology and flow cytometry in mammary carcinomas labeled in vivo with bromodeoxyuridine. Am J Clin Pathol 1993;100:218–222
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beresford, M., Sanghera, B., Wong, WL. et al. Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. Eur J Nucl Med Mol Imaging 33, 624 (2006). https://doi.org/10.1007/s00259-005-0037-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-005-0037-7